Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
670.8 INR | -0.07% | +4.08% | -7.63% |
Mar. 27 | Suven Pharmaceuticals Limited Announces Shifting of Registered Office | CI |
Mar. 05 | Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call |
Sales 2023 | 13.4B 161M | Sales 2024 * | 10.9B 131M | Capitalization | 171B 2.05B |
---|---|---|---|---|---|
Net income 2023 | 4.11B 49.29M | Net income 2024 * | 3.34B 40.05M | EV / Sales 2023 | 8.97 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 15.7 x |
P/E ratio 2023 |
29.2
x | P/E ratio 2024 * |
51.1
x | Employees | 1,193 |
Yield 2023 * |
0.35% | Yield 2024 * |
0.26% | Free-Float | 37.48% |
Latest transcript on Suven Pharmaceuticals Limited
1 day | -0.07% | ||
1 week | +4.08% | ||
Current month | +1.93% | ||
1 month | +7.23% | ||
3 months | +9.55% | ||
6 months | +17.53% | ||
Current year | -7.63% |
Managers | Title | Age | Since |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 23-09-28 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | Dec. 31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 23-09-28 | |
Shweta Jalan
BRD | Director/Board Member | 48 | Nov. 08 |
Director/Board Member | 62 | Nov. 08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 670.8 | -0.07% | 2 957 |
24-05-03 | 671.2 | +0.25% | 1,762 |
24-05-02 | 669.5 | +1.74% | 3,969 |
24-04-30 | 658 | +2.11% | 2,624 |
24-04-29 | 644.4 | -2.04% | 7,479 |
Delayed Quote Bombay S.E., May 06, 2024 at 04:20 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+22.23% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.17% | 198B | |
-10.96% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- SUVENPHAR Stock
- SUVENPHAR Stock